AbbVie, through its Allergan acquisition, is a biopharmaceutical company focused on immunology, oncology, neuroscience, and aesthetics. The company combines scientific innovation with commercial expertise to deliver therapeutic and aesthetic solutions addressing complex medical and patient needs.
Solutions include prescription medicines, Botox aesthetics, medical devices, and therapeutic treatments across multiple disease areas. AbbVie supports healthcare providers with science-based products and patient-focused innovation.
Sustainability priorities include ethical research, access to medicines, environmental responsibility, and strong corporate governance. The company integrates ESG frameworks into long-term business strategy and operations.
AbbVie operates in more than 70 countries with global manufacturing, R&D, and commercial infrastructure supporting diversified healthcare markets.
Further Details
Some additional details about the company are listed below:
| Parameter | Details |
|---|---|
| AbbVie (Allergan) | https://www.abbvie.com/ |
| Company Name | AbbVie (Allergan) |
| Application Areas | Immunology, aesthetics, neuroscience, chronic conditions |
| Sustainability Recognition | Ethical research and patient-focused innovation |
| Key Technologies | Biologic drug development, aesthetic treatment platforms |
| Industry | Biopharmaceuticals & medical aesthetics |
| Core Focus | Innovative therapeutics and aesthetic medicine solutions |
| Solutions Offered | Biologic drugs, aesthetic treatments, therapeutic medicines |